港股异动 | 荃信生物-B(02509)涨超8% 拟收购赛孚士剩余股权 促进两款核心管线产品新药上市申请
Last Update:
29 6 月, 2026
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.